Insights

Benchmark International ha gestionado con éxito la operación entre Triducive Partners Ltd y Bioscript Group Limited

May 26, 2026

Benchmark International se complace en anunciar la transacción entre Triducive y Bioscript.

Fundada en 2009 y con sede en St Albans, Hertfordshire, Triducive trabaja con muchas de las principales empresas farmacéuticas del mundo, incluidas AstraZeneca y Johnson & Johnson. Los cofundadores Tim Warren y Nick Williams permanecerán en la empresa, lo que garantizará la continuidad para los clientes a medida que Triducive se integre en la división Data and Insights de Bioscript.

Bioscript es un grupo especializado en comunicaciones sanitarias y servicios científicos respaldado por Sovereign Capital Partners.

Triducive es la quinta adquisición completada por Bioscript desde que Sovereign invirtió en el negocio en 2021. La adición refuerza aún más la capacidad de Bioscript para apoyar a los clientes en toda la cadena de valor de asuntos médicos, desde la generación de evidencia hasta la publicación, juntas asesoras y comunicaciones científicas.

Concierte una consulta confidencial.

Tim Warren, socio director de Triducive, afirmó: "La incorporación a Bioscript Group nos ofrece una plataforma para ampliar el impacto de nuestro trabajo. La capacidad de combinar nuestra generación de conocimientos con la experiencia en comunicación de Bioscript permitirá a los clientes traducir las pruebas en acciones con mayor eficacia y alcance. La coincidencia de valores y ambiciones hace que esta asociación sea apasionante para nuestro equipo y nuestros clientes".

Gabrielle Silver, consejera delegada de Bioscript, afirmó: "Triducive aporta una fuerza excepcional en la generación del tipo deconocimientos estructurados y basados en la prácticaque ayudan a los clientes a entender lo que realmente influye en la toma de decisiones clínicas y políticas. Al combinar esto con la experiencia en comunicación estratégica de Bioscript, podemos apoyar a los clientes con programas basados en la experiencia del mundo real".

Dominic Dalli, socio director de Sovereign, ha declarado: "Triducive es una incorporación de alta calidad que refuerza significativamente la propuesta de Bioscript. Su experiencia en destilar el consenso clínico de expertos se sitúa en el extremo superior de la cadena de valor de los asuntos médicos, y su combinación con la plataforma de comunicaciones de Bioscript crea una oferta atractiva e integrada para los clientes."

Programar una llamada

Americas: Sam Smoot at +1 (813) 898 2350 / [email protected]

Europe: Michael Lawrie at +44 (0) 161 359 4400 / [email protected]

Africa: Anthony McCardle at +27 21 300 2055 / [email protected] 

 

ABOUT BENCHMARK INTERNATIONAL:

Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled transactions across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network, as well as the #1 Sell-side Privately Owned M&A Advisor in the World by PitchBook’s and LSEG's Global League Tables.

The content provided by Benchmark International, including articles, blog posts, videos, and other media, is for general informational purposes only and does not constitute legal, financial, investment, or business advice. While we strive for accuracy, the information may be based on third-party sources, market trends, and evolving industry data that are not independently verified or guaranteed to be current or complete. Any opinions expressed are those of the authors and do not necessarily reflect the views of Benchmark International. Market trends, forecasts, and forward-looking statements are inherently uncertain and subject to change. Nothing in our content should be relied upon as a substitute for personalized advice from qualified professionals. Benchmark International disclaims all liability for any loss or damage resulting from reliance on this content. Always consult with appropriate experts before making business decisions.

Share This Post
Categories

Get These Insights Delivered Directly To Your Email

Explore our curated collection today and stay ahead of the curve in M&A.

Related Posts
How to Attract the Right Buyers: What Makes a Business More ValuableIn the dynamic world of mergers and acquisitions (M&A), selling your business is a complex process that requires strategic planning, valuation expertise, and an understanding of what potential buyers are looking for. Buyers and investors are driven by various motives, including growth acceleration, market expansion, and portfolio diversification. Successfully attracting the right buyers can significantly impact the sale price and the overall success of the transaction. But what exactly can make your business more valuable and appealing to prospective buyers? Let’s explore the key factors that may enhance your company's attractiveness in M&A and how you can position your business for maximum appeal.Why Multi-Party Sale Processes Are an Opportunity for BuyersTo many acquirers, the words “competitive process” still carry an undertone of friction. They suggest distraction, inflated expectations, unnecessary pressure, and the risk of being used as a price tension rather than a serious counterparty. Yet this interpretation often misses the deeper reality. For most business owners, particularly founders and long-tenured operators, a multi-party sale process is not an act of aggression; it is an act of responsibility – to themselves, to the business, and to the buyer.
Not Finding What You're Looking For?
Ready to dive into our featured M&A content and gain valuable insights for your business?